(Q39338900)

11 September 2017

title

Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience (English)

1 reference

11 September 2017

0 references

0 references

0 references

ankylosing spondylitis

1 reference

Liisa Konttinen

1

1 reference

11 September 2017

Riitta Tuompo

2

1 reference

11 September 2017

Tea Uusitalo

3

1 reference

11 September 2017

Riitta Luosujärvi

4

1 reference

11 September 2017

Kari Laiho

5

1 reference

11 September 2017

Jukka Lähteenmäki

6

1 reference

11 September 2017

Maija Puurtinen-Vilkki

7

1 reference

11 September 2017

Ritva Lanteri

8

1 reference

11 September 2017

Saara Kortelainen

9

1 reference

11 September 2017

Helena Karilainen

10

1 reference

11 September 2017

Tuire Varjolahti-Lehtinen

11

1 reference

11 September 2017

Dan Nordström

12

1 reference

11 September 2017

ROB-FIN Study Group

13

1 reference

11 September 2017

publication date

1 March 2007

1 reference

11 September 2017

published in

Clinical Rheumatology

1 reference

11 September 2017

volume

26

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

1693-1700

1 reference

Pharmacological treatment of ankylosing spondylitis: a systematic review

11 September 2017

cites work

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis--a population-based survey

1 reference

12 December 2020

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study

1 reference

12 December 2020

Musculoskeletal manifestations and autoimmune diseases related to new biologic agents

1 reference

12 December 2020

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial

1 reference

12 December 2020

Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience.

1 reference

12 December 2020

Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study

1 reference

12 December 2020

Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety

1 reference

12 December 2020

Advances in targeted therapy: safety of biological agents

1 reference

12 December 2020

Biological treatment in rheumatic diseases: results from a longitudinal surveillance: adverse events

1 reference

12 December 2020

Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)

1 reference

12 December 2020

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches

1 reference

12 December 2020

Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides

1 reference

12 December 2020

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis

1 reference

12 December 2020

Clinical investigation of methotrexate in the treatment of ankylosing spondylitis

1 reference

12 December 2020

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

12 December 2020

An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis

1 reference

12 December 2020

Management and treatment of ankylosing spondylitis

1 reference

12 December 2020

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

1 reference

12 December 2020

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

12 December 2020

Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study

1 reference

12 December 2020

Is methotrexate effective in ankylosing spondylitis?

1 reference

12 December 2020

Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial

1 reference

12 December 2020

Consequences of immunogenicity to the therapeutic monoclonal antibodies ReoPro and Remicade

1 reference

12 December 2020

Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

1 reference

12 December 2020

Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study

1 reference

12 December 2020

Effectiveness of anakinra in rheumatic disease in patients naive to biological drugs or previously on TNF blocking drugs: an observational study

1 reference

12 December 2020

10.1007/S10067-007-0574-5

Identifiers

DOI

1 reference

11 September 2017

1 reference